Total body recumbent stepping vs treadmill walking in supervised exercise therapy: A pilot study.
Dereck L Salisbury1, Kari Swanson1, Rebecca Jl Brown1,2
1School of Nursing, University of Minnesota, Minneapolis, MN, USA.
Vascular Medicine (London, England)
|January 12, 2022
Summary
Total body recumbent stepping (TBRS) is a feasible and safe alternative to treadmill walking for supervised exercise therapy in peripheral artery disease (PAD) patients, showing comparable preliminary efficacy.
Area of Science:
- Cardiovascular Exercise Physiology
- Rehabilitation Medicine
Background:
- Treadmill walking is standard for supervised exercise therapy (SET) in peripheral artery disease (PAD).
- Alternative modalities may offer improved patient tolerance and comparable effectiveness.
- The "Stepper Study" investigated treadmill walking (TM) versus total body recumbent stepping (TBRS) in PAD SET.
Purpose of the Study:
- To compare the feasibility, safety, and preliminary efficacy of TBRS versus TM exercise in SET for PAD.
- To assess adherence, exercise dose, and adverse events between the two modalities.
Main Methods:
- A single-blind, randomized pilot study involving 19 PAD patients in a 12-week SET program.
- Participants were randomized to either TM (n=9) or TBRS (n=10) exercise groups.
- Feasibility, safety, and efficacy outcomes, including 6-minute walk distance, were assessed.
Main Results:
- SET attendance was higher in the TBRS group (86%) compared to the TM group (71%).
- TBRS achieved a higher session exercise dose (MET-minutes) than TM (144.7 vs 117.6).
- No significant differences in 6-minute walk distance improvement were observed between groups after baseline adjustment.
Conclusions:
- Total body recumbent stepping (TBRS) is a feasible and safe exercise modality for supervised exercise therapy in peripheral artery disease (PAD).
- This pilot study suggests preliminary efficacy for TBRS in SET programs, comparable to treadmill walking.
- Larger randomized studies are warranted to confirm these findings and establish TBRS as a viable alternative in PAD treatment.


